The New York Times (NYT) CEO Meredith Kopit Levien said that the company “will not be cowed” by President Donald Trump’s $15 billion defamation lawsuit. The Financial Times first reported on the matter. On Wednesday, Trump filed a $15 billion defamation and libel suit against NYT, accusing the newspaper of being a “virtual mouthpiece” for the Democrats. In response, Levien accused the president of using an “anti-press playbook.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Since beginning his second term, Trump has repeatedly targeted news publications, alleging that they were spreading misinformation and publishing damaging reports about him, his family, and his businesses. In July, he also filed a $10 billion lawsuit against The Wall Street Journal on similar grounds, linked to disgraced financier Jeffrey Epstein.
NYT’s Stance on the Lawsuit
In her first public statements since the lawsuit, Levien said, “The lawsuit has no merit. It lacks any legitimate legal claims.” She argued that the goal was to silence independent journalism and prevent the kind of fact-based reporting the Times is known for. Nonetheless, she emphasized that the paper would not be pressured by such tactics.
Levien also drew parallels with authoritarian tactics in countries such as Turkey and Hungary, where leaders are elected but still “work to quash opposition to the regime.” She concluded by stating, “The Times will continue to follow the facts wherever they may lead, even when that is to uncomfortable places.”
The clash between Trump and a major US newspaper highlights his growing legal campaign against the media and raises questions about press freedom. This is his fourth multibillion-dollar defamation suit since March 2024. Earlier this year, Disney’s (DIS) ABC News and Paramount’s (PSKY) CBS settled for $15 million and $16 million, respectively.
Is NYT Stock a Buy, Hold, or Sell?
Analysts remain divided on New York Times’ long-term outlook. On TipRanks, NYT stock has a Moderate Buy consensus rating based on three Buys and three Hold ratings. The average New York Times price target of $61 implies 4.3% upside potential from current levels. Year-to-date, NYT stock has gained 13.4%.
